
Overview
Synevo is a medical laboratory in Poland offering blood tests and comprehensive laboratory diagnostics at more than 180 collection points. Its services include complete blood counts, TSH, ferritin, glucose, cortisol, lipid profiles, thyroid panels, hormonal panels, oncology marker packages and health check-up packages; tests can be performed without a referral or appointment, with results available in the MySynevo app or browser.
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
From the notes
| Current income tax (CIT due) | $1,700,102 |
Filing timeliness
Financial statements were filed on time, on average 54 days early. All were audited by a statutory auditor.
- 202519/05/2026
- 202405/05/2025
- 202317/06/2024
- 202203/05/2023
- 202109/06/2022
- 202019/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
- synevo.plLaboratorium medyczne Synevo – badania krwi i diagnostykaWooCommerceWordPress 3.7ElementorGoogle Tag ManagerRRank Math
- veracity.com.plVERACITY prenatal test – comprehensive, non-invasive testing | VERACITYGoogle Tag ManagerNginx
Public procurement
16 tenders recorded as contractor: 11 national ($689,116) and 5 EU ($998,296).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 8, 2026 | KBL/2/2026 - Call for tenders for diagnostic laboratory and genetic tests for Instytut „CZMP” | $19,195$19,195 | Instytut Centrum Zdrowia Matki Polki | |
| Apr 21, 2026 | Provision of healthcare services in the field of laboratory testing | –– | Wojewódzki Szpital Zespolony Im. Stanisława Rybickiego w Skierniewicach | |
| Apr 8, 2026 | KBL/1/2026 - Call for tenders for the provision of diagnostic laboratory and genetic tests for Instytut „CZMP” | $33,956$33,956 | Instytut Centrum Zdrowia Matki Polki |
The company is the contractor in 45 public sector contracts, worth USD 1.00m in total. They were signed with 18 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 12, 2026 | wykonanie badania przeciwciała przeciwko kanałom wapniowym anty-VGCC | $159.37 | Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie | |
| Nov 9, 2026 | Lot 1 - Index Kappa (kFLC index) - determination of Kappa light chains in CSF and serum | $2,836 | Samodzielny Publiczny Szpital Kliniczny Nr 1 Im.Prof.Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Nov 9, 2026 | wykonanie badania poziomu enzymu TPMT z surowicy krwi | $135.06 | Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2016. In 2026 it is performing 7 contracts with a total value of USD 888.01k. All its contracts were worth USD 5.26m in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Preventive health programmes | pomorskie | 1 | USD 432.20k |
| Preventive health programmes | śląskie | 1 | USD 171.50k |
| Preventive health programmes | kujawsko-pomorskie | 1 | USD 93.22k |
| Preventive health programmes | wielkopolskie | 1 | USD 85.44k |
| Preventive health programmes | lubuskie | 1 | USD 37.49k |
Job offers
The company has its own careers page: synevo.pl/o-nas/kariera.
Authorized Representatives
Manner of representation
The following is authorized to submit declarations of will and sign on behalf of the company: in the case of a one-person management board, one member of the management board; in the case of a multi-member management board, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Medicover Investment B.v. | 54,434 | $7,351,971.91 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Jonas and Christina af Jochnick Foundation (Liechtenstein) group. Its direct owner is Medicover Investment B.V. (Netherlands). The group has 9 companies, 7 of them abroad.
| Name | Country |
|---|---|
| ABC Medicover Holdings B.V. | |
| Belro Medical | |
| Celox Group Limited | |
| Celox Holding AB | |
| Medicover AB |
Bank accounts
Registered as a VAT taxpayer on 2005-06-01.
58 1050 0086 1000 0090 8238 9587
69 1050 0086 1000 0090 8707 7690
51 1050 0086 1000 0023 0641 0578
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.7MPLN 1,729,077 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medicover sp. z o.o. | $720,657,064.54 | medicover.pl | ||
| Diagnostyka S.A. | $609,609,743.85 | diag.pl | ||
| Alab Laboratoria sp. z o.o. | $195,272,294.22 | alab.pl | ||
| Polmed S.A. | $107,913,555.50 | polmed.pl | ||
| Badaj.To sp. z o.o. | $38,871,076.42 | badaj.to | ||
| Invicta sp. z o.o. | $32,719,940.95 | invicta.pl | ||
| Gyncentrum sp. z o.o. | $22,506,902.40 | dnahometest.pl | ||
| Alab Plus sp. z o.o. | $17,069,532.31 | alabplus.pl | ||
| Medgen Kamila Czerska I Wspólnicy sp. k. | $12,536,540.98 | medgen.pl | ||
| DR N.Med.Teresa Fryda Laboratorium Medyczne sp. z o.o. | $12,514,944.31 | fryda.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-03-05 | PKD change (Removed: 72.11.Z; Added: 86.90.E) | |
| 2018-03-14 | Address change (Gdecka 3b, 04-137, Warszawa → Ul. Zamieniecka 80/401, 04-158, Warszawa) | |
| 2015-09-22 | PKD change (Removed: 98 codes) | |
| 2013-12-30 | Address change (Gdecka 3, 04-137, Warszawa → Gdecka 3b, 04-137, Warszawa) | |
| 2013-12-30 | Share capital increase (4,221,500.00 PLN → 27,217,000.00 PLN) |
FAQ
Last updated: 2026-10-07